Jamie Stockton
Stock Analyst at Wells Fargo
(2.28)
# 2,711
Out of 4,974 analysts
22
Total ratings
46.67%
Success rate
10.81%
Average return
Main Sectors:
Stocks Rated by Jamie Stockton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Equal-Weight | $175 → $200 | $7.79 | +2,467.39% | 5 | Oct 29, 2020 | |
| OMCL Omnicell | Maintains: Equal-Weight | $74 → $84 | $33.15 | +153.39% | 2 | Oct 28, 2020 | |
| HQY HealthEquity | Maintains: Overweight | $63 → $70 | $94.05 | -25.57% | 6 | Sep 9, 2020 | |
| EVH Evolent Health | Maintains: Overweight | $19 → $17 | $9.69 | +75.44% | 2 | Jan 8, 2020 | |
| MMS Maximus | Maintains: Equal-Weight | $83 → $81 | $88.22 | -8.18% | 3 | Jan 8, 2020 | |
| IQV IQVIA Holdings | Maintains: Outperform | $140 → $160 | $186.38 | -14.15% | 2 | Feb 19, 2019 | |
| EHTH eHealth | Maintains: Market Perform | $18 → $24 | $4.03 | +495.53% | 2 | Oct 19, 2017 |
Teladoc Health
Oct 29, 2020
Maintains: Equal-Weight
Price Target: $175 → $200
Current: $7.79
Upside: +2,467.39%
Omnicell
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $74 → $84
Current: $33.15
Upside: +153.39%
HealthEquity
Sep 9, 2020
Maintains: Overweight
Price Target: $63 → $70
Current: $94.05
Upside: -25.57%
Evolent Health
Jan 8, 2020
Maintains: Overweight
Price Target: $19 → $17
Current: $9.69
Upside: +75.44%
Maximus
Jan 8, 2020
Maintains: Equal-Weight
Price Target: $83 → $81
Current: $88.22
Upside: -8.18%
IQVIA Holdings
Feb 19, 2019
Maintains: Outperform
Price Target: $140 → $160
Current: $186.38
Upside: -14.15%
eHealth
Oct 19, 2017
Maintains: Market Perform
Price Target: $18 → $24
Current: $4.03
Upside: +495.53%